DWP
BIB icon

Destiny Wealth Partners’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Destiny Wealth Partners’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-270
Closed -$22K – 272
2026
Q1 		$22K Buy
+270
New +$22.4K ﹤0.01% 643
2023
Q1 		– Sell
-270
Closed -$15.6K – 229
2022
Q4 		$15.6K Hold
270
– – ﹤0.01% 432
2022
Q3 		$13K Hold
270
– – ﹤0.01% 398
2022
Q2 		$13K Hold
270
– – ﹤0.01% 400
2022
Q1 		$17K Hold
270
– – ﹤0.01% 395
2021
Q4 		$22K Hold
270
– – ﹤0.01% 382
2021
Q3 		$26K Buy
+270
New +$27.3K 0.01% 354
2021
Q2 		– Sell
-270
Closed -$23K – 214
2021
Q1 		$23K Hold
270
– – ﹤0.01% 349
2020
Q4 		$23K Buy
+270
New +$20.9K ﹤0.01% 348

Other funds holding BIB

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return
KFS
Kaizen Financial Strategies Campbell, California $308M AUM 41.73% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $474M AUM 95.11% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return

Destiny Wealth Partners's BIB Position: Q2 2026 in Review

Destiny Wealth Partners sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2026, closing a stake of 270 shares — an estimated $22K sold.

Destiny Wealth Partners first reported a position in BIB in Q4 2020 and held it in 9 quarters. The position peaked at $26K in Q3 2021. 20 funds tracked by Wall St. Rank hold BIB as of Q2 2026.

  • Destiny Wealth Partners reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Destiny Wealth Partners sold 270 ProShares Ultra NASDAQ Biotechnology shares in Q2 2026, an estimated $22K.
  • Destiny Wealth Partners first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2020 and held it in 9 quarters.
  • Destiny Wealth Partners's ProShares Ultra NASDAQ Biotechnology position peaked at $26K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.